Depression Information

Vagus Nerve Stimulation as a Treatment for Depression to be Launched in May


Final FDA approval of vagus nerve stimulation as a therapy for chronic or recurrent treatment-resistant depression to be issued in May. Psychiatrists will then officially be able to prescribe this remarkable, life changing therapy for patients.

On April 7th, 2005, the manufacturer of the vagus nerve stimulator( Cyberonics, Inc.) announced that it had been notified by the U.S. Food and Drug Administration(FDA) that one the few remaining conditions of final FDA approval had been satisfied. Cyberonics also announced that it was very confident that the two remaining conditions will be expeditously satisfied and that final FDA approval will be issued in May.

Robert P. ("Skip") Cummins, Cyberonics' Chairman of the Board and Chief Executive Officer commented: "This major step forward towards the accomplishment of Cyberonics' mission to improve the lives of people touched by refractory epilepsy and treatment-resistant depression (TRD) would not have been possible without the timely, diligent, interactive and cooperative efforts of the entire Dallas District Office staff led by Michael Chappell, District Director, and the Cyberonics regulatory team. Cyberonics and CDRH continue to make good progress towards our goal of satisfying the remaining conditions of final TRD approval."

The official launch of vagus nerve stimulation as a treatment for depression will take place at the American Psychiatric Association's Annual Meeting at the World Congress Center in Atlanta from May 21st to May 25th. The Annual Meeting will be attended by over 20,000 psychiatrists.

Major depressive disorder is one of the most prevalent and serious illnesses in the U.S., affecting nearly 19 million Americans every year. Depression is the second leading cause of disability for the general population and the leading cause of disability for American women. Approximately 20 percent of depressed Americans, or approximately four million people, experience chronic or recurrent treatment-resistant depression that has failed to respond to multiple antidepressant treatments. If approved, the VNS Therapy System will be the first implantable device-based treatment for depression and the first treatment developed, studied and labeled specifically for patients with treatment-resistant depression.

Vagus nerve stimulation will be the mainstream treatment for chronic or treatment-resistant depression. Over four million American suffer from chronic depression. The final FDA approval will be considered one of the major breakthroughs in medical device history.

You can learn more at http://www.VagusNerveStimulator.com. There is a free electronic newsletter to keep you up-to-date.

Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

The book will be exhibited at the American Psychiatric Association's Annual Meeting in May.

He is editor the http://www.VagusNerveStimulator.com Web Site


MORE RESOURCES:

Low Vitamin D Tied to Depression in Older Adults
Washington Post, United States - 1 hour ago
The Dutch study, published in the May issue ofArchives of General Psychiatry, supports previous speculation by researchers that vitamin D, depression and ...
Vitamin D Use Linked to Lower Mortality in Kidney Patients U.S. News & World Report
all 17 news articles


Poll: Many see "depression" in US economy
Bizjournals.com, NC - 5 hours ago
Many of the voters in a recent informal Los Angeles Business from bizjournals poll said they saw the economy currently in a "depression". ...


Shedding light on depression
Concord Journal,  USA - 3 hours ago
By Kerri Roche/Staff Writer Newton native Julie Totten already lost one family member to the dark, consuming world of depression and wants to try to save ...


Mothers' Depression Linked To Young Children's Injuries
Science Daily (press release) - May 15, 2008
The study's findings, published May 14 in the Advanced Access edition of the Journal of Pediatric Psychology, suggest that proper treatment for depression ...


Major Depression Study Shows Success of Long-Term Treatment
Psychiatric News, CA - 8 hours ago
Another report from TADS finds that continuing depression treatment—regardless of modality—helps more adolescent patients. Most patients who achieved a ...


Tropical depression 'Cosme' intensifies slightly
ABS CBN News, Philippines - May 15, 2008
Tropical depression "Cosme" strengthened slightly as it continued to batter Oriental Mindoro, according to weather bureau Philippine Atmospheric, ...
‘Cosme’ maintains strength but remains stationary GMA news.tv
2 tropical depressions to induce more rains Inquirer.net
Cyclone Watch: Tropical Depression ‘Cosme’ ABS CBN News
GMA news.tv - GMA news.tv
all 34 news articles


Cornbread: Great Depression staple in Japan
Delta Farm Press, NE - 11 hours ago
My dad was born in the early 1920s and grew up on a briar patch of a farm in Leon County, Texas, in the midst of the Great Depression. ...


Psychological treatment of depression: A meta-analytic database of ...
7thSpace Interactive (press release), NY - 14 hours ago
A large number of randomized controlled studies have clearly demonstrated that psychological interventions are effective in the treatment of depression. ...


Jordan High paper strikes back with survey
Los Angeles Times, CA - 10 hours ago
What exactly is clinical depression? Clinical depression is a serious medical illness that negatively affects how you feel, the way you think, ...


Migraine, Depression Meds May Cause Problems
FOXNews - May 15, 2008
People suffering from migraines and depression need to be careful when mixing medication for the two, according to a study in Thursday’s issue of the New ...

Depression - Google News

home | site map
© Care Online 2006